ALAL/MPAL with BCL11B rearrangement/activation (r/a) accounts for 10–15% of MPAL cases, and approximately one-third of T/myeloid MPAL cases [23,24,25]. The gene discussed is BCL11B; the disease is mixed phenotype acute leukemia.